FDA’s Secret Drug Loophole: Banned Factories Supply US
ProPublica reveals FDA's loophole allowing over 150 drugs from banned factories with mold/filth to enter the US, raising safety concerns and potential patient harm.
US Drug Prices: Bipartisan Bill Targets High Costs
A bipartisan bill aims to penalize US medicine firms charging higher prices than other rich nations. Revlimid's price disparity highlights the issue. The debate involves research costs and government intervention.